American Peptide Company Forms R&D Group

American Peptide Company has announced the formation of a R&D group. Created to offer more robust technology capabilities to a growing roster of global pharmaceutical and biotech customers, the R&D group will be based at the company’s California, US facility and will be tasked with the development of innovative new products and services.

“The new R&D group will better enable American Peptide Company to meet the complex and evolving needs of our global customer base,” says Takahiro Ogata, president & COO. “The R&D group and the technological capabilities they offer will ultimately help our customers more effectively drive bioactive peptides identified as potential drug targets through the discovery and development phase.”